GW Cancer Center

The GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. The study is led by Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the GW Cancer Center.
A research team led by Yanfen Hu, PhD, is studying the role of the tumor suppressor BRCA1 in the homologous recombination pathway of DNA double-strand break repair.
Researchers at the GW Cancer Center found that sun safety practices for attendees at skin cancer screening events differ from the general public.
Mandi Pratt-Chapman, MA, associate center director of patient-centered initiatives and health equity at GW Cancer Center, spoke to LIVESTRONG for an article about what is being done in the current health care landscape to decrease health inequities for the LGBTQIA+ community.
Jeffrey S. Akman, MD ’81, RESD ’85, vice president for health affairs, Walter A. Bloedorn Professor of Administrative Medicine, and dean of the George Washington University (GW) School of Medicine and Health Sciences (SMHS), was one of three recipients of the 43rd Annual George Washington Award…
The GW Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, Jay Katzen, BA ’67, MD ’72. 
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center, has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention to provide comprehensive technical…
The GW Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.
A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.
Vishal Patel, MD, director of the Cutaneous Oncology Program at the GW Cancer Center and assistant professor of dermatology at SMHS, spoke to Today about foot melanoma.